Israel Cancer Association Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00306020
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

hemopoietic stem cell (1 trial)

Drugs in Other Trials (1)

morphine (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2